Finance

Lists
2096:HKG
Simcere Pharmaceutical Group Ltd
HK$11,02
+1,75%
(+0,19) 1D
16 ຕ.ລ., 16 ໂມງ 8 ນາທີ 14 ວິນາທີ GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2096...
Open
HK$10,85
High
HK$11,29
Low
HK$10,85
Mkt. cap
28,30 ຕື້
Avg. vol.
4,02 ລ້ານ
Volume
5,80 ລ້ານ
Dividend
1,88%
Quarterly dividend
HK$0,05
Ex-dividend date
18 ມິ.ຖ. 2025
P/E ratio
16,54
52-wk high
HK$14,38
52-wk low
HK$9,07
EPS
HK$0,67
Shares outstanding
2,57 ຕື້
No. of employees
7 ພັນ
Open
HK$10,85
High
HK$11,29
Low
HK$10,85
Mkt. cap
28,30 ຕື້
Avg. vol.
4,02 ລ້ານ
Volume
5,80 ລ້ານ
Dividend
1,88%
Quarterly dividend
HK$0,05
Ex-dividend date
18 ມິ.ຖ. 2025
P/E ratio
16,54
52-wk high
HK$14,38
52-wk low
HK$9,07
EPS
HK$0,67
Shares outstanding
2,57 ຕື້
No. of employees
7 ພັນ
News stories
From web sources and news partners
Profile
Simcere Pharmaceutical Group or Simcere Pharmaceutical is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market. Its focus is to introduce generic and pharmaceutical products for the treatment of diseases with high incidence and/or mortality rate. The company has introduced a generic anti-stroke medication under the brand name, Bicun, and an anti-cancer medication under the brand name, Endu. Its products include antibiotics, anti-stroke medications, anti-inflammatory drugs, anti-cancer medications and other medicines. In addition, it has obtained approvals from the China State Food and Drug Administration to manufacture and sell over 210 other products. Wikipedia
About Simcere Pharmaceutical Group Ltd
CEORen Jinsheng
Employees7,06 ພັນ
Founded1995
HeadquartersNanjing, Jiangsu, ຈີນ
SectorPharmaceutical industry
Previous reports
Loading Previous Earnings...
Revenue
Net income
All values in CNY
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
2,07 ຕື້
2,07 ຕື້
2,29 ຕື້
2,29 ຕື້
Cost of goods sold
365,25 ລ້ານ
365,25 ລ້ານ
382,55 ລ້ານ
382,55 ລ້ານ
Cost of revenue
365,25 ລ້ານ
365,25 ລ້ານ
382,55 ລ້ານ
382,55 ລ້ານ
Research and development expenses
465,30 ລ້ານ
465,30 ລ້ານ
412,46 ລ້ານ
412,46 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
949,52 ລ້ານ
949,52 ລ້ານ
1,01 ຕື້
1,01 ຕື້
Operating expense
1,36 ຕື້
1,36 ຕື້
1,39 ຕື້
1,39 ຕື້
Total operating expenses
1,72 ຕື້
1,72 ຕື້
1,77 ຕື້
1,77 ຕື້
Operating income
351,33 ລ້ານ
351,33 ລ້ານ
520,99 ລ້ານ
520,99 ລ້ານ
Other non operating income
-
-
-
-
EBT including unusual items
425,92 ລ້ານ
425,92 ລ້ານ
483,36 ລ້ານ
483,36 ລ້ານ
EBT excluding unusual items
348,89 ລ້ານ
348,89 ລ້ານ
531,61 ລ້ານ
531,61 ລ້ານ
Income tax expense
55,72 ລ້ານ
55,72 ລ້ານ
70,09 ລ້ານ
70,09 ລ້ານ
Effective tax rate
13,08%
13,08%
14,50%
14,50%
Other operating expenses
-56,27 ລ້ານ
-56,27 ລ້ານ
-42,94 ລ້ານ
-42,94 ລ້ານ
Net income
370,20 ລ້ານ
370,20 ລ້ານ
414,36 ລ້ານ
414,36 ລ້ານ
Net profit margin
17,86%
17,86%
18,09%
18,09%
Earnings per share
-
-
-
-
Interest and investment income
14,60 ລ້ານ
14,60 ລ້ານ
24,20 ລ້ານ
24,20 ລ້ານ
Interest expense
-23,63 ລ້ານ
-23,63 ລ້ານ
-24,61 ລ້ານ
-24,61 ລ້ານ
Net interest expenses
-9,03 ລ້ານ
-9,03 ລ້ານ
-416,00 ພັນ
-416,00 ພັນ
Depreciation and amortization charges
-
-
-
-
EBITDA
449,72 ລ້ານ
449,72 ລ້ານ
606,04 ລ້ານ
606,04 ລ້ານ
Gain or loss from assets sale
-115,50 ພັນ
-115,50 ພັນ
-
-
AI content may include mistakes. Learn more
ແອັບຂອງ Google